ரிஷி மேத்தா News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from ரிஷி மேத்தா. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In ரிஷி மேத்தா Today - Breaking & Trending Today

Cyble Appoints Former MobileIron & IBM Executive Tim Youm as Regional Sales Director – Australia & New Zealand


Cyble Appoints Former MobileIron & IBM Executive Tim Youm as Regional Sales Director – Australia & New Zealand
on July 02 2021 8:30 AM
ALPHARETTA, Ga. (BUSINESS WIRE) Cyble, an AI-powered, Y Combinator-backed, cyber threat intelligence company that empowers organizations with darkweb & cybercrime monitoring and mitigation services, today announced that Tim Youm, ex- Regional Sales Director (Asia Pacific) at MobileIron and former Security SW Sales Leader at IBM Australia & New Zealand, has joined hands with Cyble as the Regional Sales Director – ANZ region.
In his new role at Cyble, Tim has been entrusted with streamlining Cyble’s sales operations in Australia and New Zealand. He will be working on expanding Cyble s outreach with end-user clients and partners to better understand their cybersecurity needs and integrate Cyble s offerings in the region. This news follows the recent announcement of Rishi Mehta, former Senior Director – Technology - at Target, takin ....

United States , New Zealand , New Zealanders , Mobileiron Asia Pacific , Beenu Arora , Mandar Patil , Tim Youm , International Market , Sales Director , Asia Pacific , Regional Sales Director , Hrishi Mehta , Senior Director , Chief Information Security Officer , Australian Government , Digital Economy Strategy , Customer Success , Digital Sales Coach , Mobileiron Asia Pacific Regional Business , ஒன்றுபட்டது மாநிலங்களில் , புதியது ஜீலாந்து , இருந்தது அரோரா , மண்டர் பாட்டீல் , சர்வதேச சந்தை , விற்பனை இயக்குனர் , ஆசியா பெஸிஃபிக் ,

Johnson & Johnson's COVID shot could return by late this week with some extra safety warnings: Fauci


Apr 19, 2021 9:45am
One safety recommendation being considered for J&J s COVID-19 vaccine? Not treating patients who have clotting symptoms with the popular blood thinner heparin, the FDA says. (NIAID)
Less than a week after U.S. officials halted Johnson & Johnson s COVID-19 vaccine rollout, they re now poised to recommend that vaccinations resume, potentially with new guidance or restrictions, NIAID chief Anthony Fauci said over the weekend.
The U.S. should know by Friday when Johnson & Johnson s COVID-19 vaccine will be back on the menu though it could come with new restrictions or safety warnings, Fauci, who also serves as chief medical advisor to the president, told CNN s Dana Bash on Sunday.  ....

Los Angeles , Anthony Fauci , University Of Southern California , Advisory Committee On Immunization Practices , European Medicines Agency , Advisory Committee , Immunization Practices , Fierce Pharma , Hrishi Mehta , Keck Hospital , Southern California , Wall Street Journal , லாஸ் ஏஞ்சல்ஸ் , பல்கலைக்கழகம் ஆஃப் தெற்கு கலிஃபோர்னியா , நோய்த்தடுப்பு ப்ர்யாக்டிஸஸ் , கடுமையான பார்மா , ரிஷி மேத்தா , கேக்க் மருத்துவமனை , தெற்கு கலிஃபோர்னியா , சுவர் தெரு இதழ் ,

Doctors say clot treatment advice key to U.S. resuming J&J COVID vaccines


Doctors say clot treatment advice key to U.S. resuming J&J COVID vaccines
By Deena Beasley
Reuters
(Reuters) - Resuming the use of Johnson & Johnson s COVID-19 vaccine in the United States will require clear guidelines for the medical community on how to best treat patients that develop a rare type of blood clot, as well as alerting vaccine recipients to be aware of the telltale symptoms, according to heart doctors and other medical experts.
    U.S. health regulators recommended last week that use of the J&J vaccine be paused after six cases of rare brain blood clots, accompanied by low platelet levels, were reported in women following vaccination, out of some 7 million people who have received the shot in the United States. A panel of expert advisors to U.S. health agencies will meet later this week to determine whether the pause should continue, with a decision expected as early as Friday. ....

United States , Michele Gershberg , Julie Steenhuysen , Anthony Fauci , Deena Beasley , Joe Biden , Lisa Shumaker , Los Angeles , Jeffrey Berger , University Of California At Los Angeles , National Institute For Allergy , University Of Nebraska Medical Center , Drug Administration , University Of Southern California , Astrazeneca Plc , American Heart Association On , York University , President Joe Biden , Hrishi Mehta , Keck Hospital , Southern California , American Heart Association , New York , New England Journal , Nebraska Medical Center , National Institute ,